Lexaria Bioscience Corp. (LEXX)
NASDAQ · Healthcare
Lexaria Bioscience Corp. EPS 2016–2025
Lexaria Bioscience Corp. annual/quarterly eps history and growth rate from 2023 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Lexaria Bioscience Corp. eps for the quarter ending February 28, 2026 was $0.06, a 60.00% decrease year-over-year.
- Lexaria Bioscience Corp. annual eps for 2025 was $0.66, a 40.43% increase from 2024.
- Lexaria Bioscience Corp. annual eps for 2024 was $0.47, a 53.47% decrease from 2023.
- Lexaria Bioscience Corp. annual eps for 2023 was $1.01.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Lexaria Bioscience Corp. EPS — FAQ
Lexaria Bioscience Corp. (LEXX) eps over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Lexaria Bioscience Corp.'s eps?
Lexaria Bioscience Corp. (LEXX) reported eps of $-0.66 for fiscal 2025.
Where can I see LEXX's eps history?
The chart and table above show Lexaria Bioscience Corp.'s eps by year and by quarter, including the growth rate.